Sean McNealy has reported a significant transaction involving his holdings in Abacus Global Management, Inc. The filing, made on November 4, 2026, reveals that McNealy acquired 28,027 shares of common stock on October 30, 2026, valued at $8.47 per share. This transaction is noteworthy as it underscores McNealy's ongoing investment in the company and his role as a substantial shareholder.
Abacus Global Management, Inc. operates in the investment advice sector, as indicated by its SIC classification of 6282. The company is based in Orlando, Florida, and has undergone several name changes in recent years, previously known as Abacus Life, Inc. and East Resources Acquisition Co. McNealy, who is not listed as an officer or director, holds a significant ownership stake, making his transactions particularly relevant to stakeholders.
According to the filing, McNealy's recent transaction involved contributing shares to the Fidelity Exchange Fund. As stated in the filing, "Represents shares of the Issuer's common stock contributed by the Reporting Person to the Fidelity Exchange Fund in exchange for an interest in the Fund." Following this transaction, McNealy holds a total of 12,478,625 shares indirectly through a limited liability company (LLC) jointly owned with his spouse, along with 300 shares held directly.
This update may impact various stakeholders, including investors and analysts, who closely monitor ownership changes within the company. McNealy's substantial indirect ownership through the LLC and his recent transactions could influence investor perceptions and the company's governance dynamics.
The filing does not specify what happens next regarding McNealy's holdings or any future transactions. However, given the recent activity, it is likely that observers will continue to watch for further disclosures from McNealy and Abacus Global Management.
Read Next
Monopar Therapeutics Director Reports Stock Transactions
Monopar Therapeutics director reports stock transactions
Qasem Rami acquires 4,410 shares of KBR, Inc.
Alaska Air Group COO Jason Berry Reports Stock Transactions
Horizon Airlines CEO Andrea Schneider Reports Stock Transactions
Sokolove Jeremy Brett acquires shares in Vor Biopharma





